Industrial - Distribution
Build Your Comparison
Side-by-side financial analysisStock Comparison
TRNS vs SPXC vs NVST vs DHR vs ROP
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
Medical - Equipment & Services
Medical - Diagnostics & Research
Industrial - Machinery
TRNS vs SPXC vs NVST vs DHR vs ROP — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Industrial - Distribution | Industrial - Machinery | Medical - Equipment & Services | Medical - Diagnostics & Research | Industrial - Machinery |
| Market Cap | $852M | $11.54B | $4.01B | $127.47B | $34.48B |
| Revenue (TTM) | $333M | $2.35B | $2.81B | $24.78B | $8.12B |
| Net Income (TTM) | $7M | $254M | $68M | $3.69B | $1.71B |
| Gross Margin | 32.6% | 37.7% | 55.1% | 60.7% | 69.4% |
| Operating Margin | 4.1% | 16.9% | 9.0% | 21.0% | 28.1% |
| Forward P/E | 51.9x | 28.7x | 17.2x | 21.3x | 15.3x |
| Total Debt | $129M | $498M | $1.71B | $18.42B | $9.30B |
| Cash & Equiv. | $5M | $364M | $1.21B | $4.62B | $297M |
TRNS vs SPXC vs NVST vs DHR vs ROP — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Transcat, Inc. (TRNS) | 100 | 352.9 | +252.9% |
| SPX Technologies, I… (SPXC) | 100 | 559.1 | +459.1% |
| Envista Holdings Co… (NVST) | 100 | 116.6 | +16.6% |
| Danaher Corporation (DHR) | 100 | 114.9 | +14.9% |
| Roper Technologies,… (ROP) | 100 | 86.3 | -13.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TRNS vs SPXC vs NVST vs DHR vs ROP
Each card shows where this stock fits in a portfolio — not just who wins on paper.
TRNS ranks third and is worth considering specifically for growth.
- 19.2% revenue growth vs DHR's 2.9%
SPXC is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 14.2%, EPS growth 17.9%, 3Y rev CAGR 15.7%
- 14.3% 10Y total return vs TRNS's 7.7%
- Lower volatility, beta 1.38, Low D/E 22.3%, current ratio 2.48x
- PEG 1.51 vs DHR's 35.21
NVST lags the leaders in this set but could rank higher in a more targeted comparison.
Among these 5 stocks, DHR doesn't own a clear edge in any measured category.
ROP carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 12 yrs, beta 0.32, yield 1.0%
- Beta 0.32, yield 1.0%, current ratio 0.52x
- Lower P/E (15.3x vs 21.3x), PEG 1.59 vs 35.21
- 21.1% margin vs TRNS's 2.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 19.2% revenue growth vs DHR's 2.9% | |
| Value | Lower P/E (15.3x vs 21.3x), PEG 1.59 vs 35.21 | |
| Quality / Margins | 21.1% margin vs TRNS's 2.0% | |
| Stability / Safety | Beta 0.32 vs NVST's 1.45, lower leverage | |
| Dividends | 1.0% yield, 12-year raise streak, vs DHR's 0.7%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +44.9% vs ROP's -40.8% | |
| Efficiency (ROA) | 7.1% ROA vs NVST's 1.2%, ROIC 13.4% vs 4.8% |
TRNS vs SPXC vs NVST vs DHR vs ROP — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
TRNS vs SPXC vs NVST vs DHR vs ROP — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ROP leads in 2 of 6 categories
SPXC leads 2 • TRNS leads 0 • NVST leads 0 • DHR leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ROP leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
DHR is the larger business by revenue, generating $24.8B annually — 74.5x TRNS's $333M. ROP is the more profitable business, keeping 21.1% of every revenue dollar as net income compared to TRNS's 2.0%. On growth, SPXC holds the edge at +17.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $333M | $2.3B | $2.8B | $24.8B | $8.1B |
| EBITDAEarnings before interest/tax | $40M | $492M | $342M | $7.2B | $3.2B |
| Net IncomeAfter-tax profit | $7M | $254M | $68M | $3.7B | $1.7B |
| Free Cash FlowCash after capex | $20M | $385M | $220M | $5.3B | $2.6B |
| Gross MarginGross profit ÷ Revenue | +32.6% | +37.7% | +55.1% | +60.7% | +69.4% |
| Operating MarginEBIT ÷ Revenue | +4.1% | +16.9% | +9.0% | +21.0% | +28.1% |
| Net MarginNet income ÷ Revenue | +2.0% | +10.8% | +2.4% | +14.9% | +21.1% |
| FCF MarginFCF ÷ Revenue | +5.9% | +16.4% | +7.8% | +21.4% | +31.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +15.8% | +17.4% | +14.4% | +3.7% | +11.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -56.3% | +8.2% | +130.0% | +9.8% | +59.1% |
Valuation Metrics
Evenly matched — NVST and ROP each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 23.6x trailing earnings, ROP trades at a 85% valuation discount to TRNS's 160.1x P/E. Adjusting for growth (PEG ratio), SPXC offers better value at 2.39x vs NVST's 58.84x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $852M | $11.5B | $4.0B | $127.5B | $34.5B |
| Enterprise ValueMkt cap + debt − cash | $976M | $11.7B | $4.5B | $141.3B | $43.5B |
| Trailing P/EPrice ÷ TTM EPS | 160.11x | 45.46x | 87.86x | 35.73x | 23.59x |
| Forward P/EPrice ÷ next-FY EPS est. | 51.85x | 28.68x | 17.18x | 21.34x | 15.29x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.39x | 58.84x | 35.21x | 2.46x |
| EV / EBITDAEnterprise value multiple | 24.76x | 23.18x | 13.19x | 18.63x | 13.99x |
| Price / SalesMarket cap ÷ Revenue | 2.57x | 5.10x | 1.47x | 5.19x | 4.36x |
| Price / BookPrice ÷ Book value/share | 2.83x | 4.99x | 1.34x | 2.44x | 1.82x |
| Price / FCFMarket cap ÷ FCF | 43.60x | 47.86x | 17.40x | 24.23x | 13.83x |
Profitability & Efficiency
SPXC leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
SPXC delivers a 12.4% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $2 for NVST. SPXC carries lower financial leverage with a 0.22x debt-to-equity ratio, signaling a more conservative balance sheet compared to NVST's 0.55x. On the Piotroski fundamental quality scale (0–9), NVST scores 7/9 vs SPXC's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +2.2% | +12.4% | +2.2% | +7.1% | +8.8% |
| ROA (TTM)Return on assets | +1.4% | +7.1% | +1.2% | +4.5% | +5.0% |
| ROICReturn on invested capital | +2.6% | +13.4% | +4.8% | +5.9% | +6.1% |
| ROCEReturn on capital employed | +3.3% | +14.0% | +4.9% | +7.0% | +7.7% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 | 7 | 7 | 6 |
| Debt / EquityFinancial leverage | 0.43x | 0.22x | 0.55x | 0.35x | 0.47x |
| Net DebtTotal debt minus cash | $124M | $134M | $496M | $13.8B | $9.0B |
| Cash & Equiv.Liquid assets | $5M | $364M | $1.2B | $4.6B | $297M |
| Total DebtShort + long-term debt | $129M | $498M | $1.7B | $18.4B | $9.3B |
| Interest CoverageEBIT ÷ Interest expense | 2.81x | 10.50x | 12.76x | 18.13x | 6.50x |
Total Returns (Dividends Reinvested)
SPXC leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SPXC five years ago would be worth $38,893 today (with dividends reinvested), compared to $5,655 for NVST. Over the past 12 months, SPXC leads with a +44.9% total return vs ROP's -40.8%. The 3-year compound annual growth rate (CAGR) favors SPXC at 39.9% vs ROP's -8.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +59.7% | +13.2% | +13.4% | -21.7% | -22.5% |
| 1-Year ReturnPast 12 months | +17.9% | +44.9% | +30.4% | -11.5% | -40.8% |
| 3-Year ReturnCumulative with dividends | -1.0% | +173.6% | -22.9% | -13.0% | -24.1% |
| 5-Year ReturnCumulative with dividends | +66.3% | +288.9% | -43.4% | -15.5% | -24.7% |
| 10-Year ReturnCumulative with dividends | +769.1% | +1434.7% | -12.0% | +222.6% | +112.0% |
| CAGR (3Y)Annualised 3-year return | -0.3% | +39.9% | -8.3% | -4.5% | -8.8% |
Risk & Volatility
Evenly matched — TRNS and ROP each lead in 1 of 2 comparable metrics.
Risk & Volatility
ROP is the less volatile stock with a 0.32 beta — it tends to amplify market swings less than NVST's 1.45 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TRNS currently trades 96.3% from its 52-week high vs ROP's 58.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.35x | 1.38x | 1.45x | 0.70x | 0.32x |
| 52-Week HighHighest price in past year | $94.76 | $246.68 | $30.42 | $242.80 | $575.77 |
| 52-Week LowLowest price in past year | $50.23 | $152.79 | $18.25 | $160.93 | $305.96 |
| % of 52W HighCurrent price vs 52-week peak | +96.3% | +93.3% | +80.9% | +74.2% | +58.2% |
| RSI (14)Momentum oscillator 0–100 | 62.7 | 61.8 | 54.1 | 52.0 | 48.5 |
| Avg Volume (50D)Average daily shares traded | 155K | 561K | 2.8M | 4.2M | 1.1M |
Analyst Outlook
ROP leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: TRNS as "Buy", SPXC as "Buy", NVST as "Hold", DHR as "Buy", ROP as "Buy". Consensus price targets imply 36.6% upside for ROP (target: $458) vs 9.5% for SPXC (target: $252). For income investors, ROP offers the higher dividend yield at 0.98% vs DHR's 0.69%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $123.60 | $252.00 | $28.33 | $231.80 | $457.64 |
| # AnalystsCovering analysts | 10 | 12 | 19 | 43 | 23 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +0.7% | +1.0% |
| Dividend StreakConsecutive years of raises | 0 | 0 | — | 9 | 12 |
| Dividend / ShareAnnual DPS | — | — | — | $1.23 | $3.29 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | 0.0% | +4.2% | +2.4% | +1.5% |
ROP leads in 2 of 6 categories (Income & Cash Flow, Analyst Outlook). SPXC leads in 2 (Profitability & Efficiency, Total Returns). 2 tied.
TRNS vs SPXC vs NVST vs DHR vs ROP: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is TRNS or SPXC or NVST or DHR or ROP a better buy right now?
For growth investors, Transcat, Inc.
(TRNS) is the stronger pick with 19. 2% revenue growth year-over-year, versus 2. 9% for Danaher Corporation (DHR). Roper Technologies, Inc. (ROP) offers the better valuation at 23. 6x trailing P/E (15. 3x forward), making it the more compelling value choice. Analysts rate Transcat, Inc. (TRNS) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — TRNS or SPXC or NVST or DHR or ROP?
On trailing P/E, Roper Technologies, Inc.
(ROP) is the cheapest at 23. 6x versus Transcat, Inc. at 160. 1x. On forward P/E, Roper Technologies, Inc. is actually cheaper at 15. 3x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: SPX Technologies, Inc. wins at 1. 51x versus Danaher Corporation's 35. 21x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — TRNS or SPXC or NVST or DHR or ROP?
Over the past 5 years, SPX Technologies, Inc.
(SPXC) delivered a total return of +288. 9%, compared to -43. 4% for Envista Holdings Corp (NVST). Over 10 years, the gap is even starker: SPXC returned +1435% versus NVST's -12. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — TRNS or SPXC or NVST or DHR or ROP?
By beta (market sensitivity over 5 years), Roper Technologies, Inc.
(ROP) is the lower-risk stock at 0. 32β versus Envista Holdings Corp's 1. 45β — meaning NVST is approximately 356% more volatile than ROP relative to the S&P 500. On balance sheet safety, SPX Technologies, Inc. (SPXC) carries a lower debt/equity ratio of 22% versus 55% for Envista Holdings Corp — giving it more financial flexibility in a downturn.
05Which is growing faster — TRNS or SPXC or NVST or DHR or ROP?
By revenue growth (latest reported year), Transcat, Inc.
(TRNS) is pulling ahead at 19. 2% versus 2. 9% for Danaher Corporation (DHR). On earnings-per-share growth, the picture is similar: Envista Holdings Corp grew EPS 104. 3% year-over-year, compared to -63. 7% for Transcat, Inc.. Over a 3-year CAGR, SPXC leads at 15. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — TRNS or SPXC or NVST or DHR or ROP?
Roper Technologies, Inc.
(ROP) is the more profitable company, earning 19. 4% net margin versus 1. 6% for Transcat, Inc. — meaning it keeps 19. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ROP leads at 28. 3% versus 4. 0% for TRNS. At the gross margin level — before operating expenses — ROP leads at 69. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is TRNS or SPXC or NVST or DHR or ROP more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, SPX Technologies, Inc. (SPXC) is the more undervalued stock at a PEG of 1. 51x versus Danaher Corporation's 35. 21x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Roper Technologies, Inc. (ROP) trades at 15. 3x forward P/E versus 51. 9x for Transcat, Inc. — 36. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ROP: 36. 6% to $457. 64.
08Which pays a better dividend — TRNS or SPXC or NVST or DHR or ROP?
In this comparison, ROP (1.
0% yield), DHR (0. 7% yield) pay a dividend. TRNS, SPXC, NVST do not pay a meaningful dividend and should not be held primarily for income.
09Is TRNS or SPXC or NVST or DHR or ROP better for a retirement portfolio?
For long-horizon retirement investors, Roper Technologies, Inc.
(ROP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 32), 1. 0% yield, +112. 0% 10Y return). Both have compounded well over 10 years (ROP: +112. 0%, NVST: -12. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between TRNS and SPXC and NVST and DHR and ROP?
These companies operate in different sectors (TRNS (Industrials) and SPXC (Industrials) and NVST (Healthcare) and DHR (Healthcare) and ROP (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: TRNS is a small-cap high-growth stock; SPXC is a mid-cap quality compounder stock; NVST is a small-cap quality compounder stock; DHR is a mid-cap quality compounder stock; ROP is a mid-cap quality compounder stock. DHR, ROP pay a dividend while TRNS, SPXC, NVST do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.